Sponsor or institution
Clinical trials and research at Kardigan, Inc.
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Kardigan, Inc. that are recruiting, at sites in 12 countries (most in United States (4), Belgium (2), Denmark (2)). By phase: Phase 2/3 (2), Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 12Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Danicamtiv for genetic or familial dilated cardiomyopathy | Phase 3 | Birmingham, Alabama and 77 other locations | Recruiting | Aug 18, 2026 |
| Tonlamarsen to lower blood pressure after a hospital stay for acute severe hypertension. | Phase 2 | Arvada, Colorado and 12 other locations | Recruiting | Apr 6, 2026 |
| Danicamtiv for people with symptomatic genetic or familial dilated cardiomyopathy | Phase 2/3 | Birmingham, Alabama and 78 other locations | Recruiting | Oct 7, 2025 |
| Ataciguat to slow progression of moderate calcific aortic valve stenosis | Phase 2/3 | Birmingham, Alabama and 73 other locations | Recruiting | Jun 3, 2025 |
All recruiting trials (4)
-
Danicamtiv for genetic or familial dilated cardiomyopathy
This study tests whether danicamtiv, taken twice daily for up to five years, is safe and helps people with symptomatic genetic or familial dilated cardiomyopathy.
-
Tonlamarsen to lower blood pressure after a hospital stay for acute severe hypertension.
This trial tests whether monthly doses of tonlamarsen can lower blood pressure and reduce angiotensinogen in adults recently discharged after treatment for acute severe hypertension.
-
Danicamtiv for people with symptomatic genetic or familial dilated cardiomyopathy
This trial will test whether the oral drug danicamtiv can improve heart function and symptoms in adults with symptomatic genetic or familial dilated cardiomyopathy.
-
Ataciguat to slow progression of moderate calcific aortic valve stenosis
This trial will test whether ataciguat can slow valve calcium buildup and disease progression in adults with moderate aortic valve stenosis.
Quick answers
How many clinical trials run by Kardigan, Inc. are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (4 trials), Belgium (2 trials), Denmark (2 trials), France (2 trials), Hungary (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2, Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.